Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. W. Huang, H. C. Tsai, C. M. Chen, Y. Y. Yu, G. H. Shen, W. T. Yang (Changhua, Taichung, Taiwan). Evaluate the potential of IP-10 as biomarker for the MDR-TB treatment outcome. Eur Respir J 2013; 42: Suppl. 57, 2785

Member's Comments

No comment yet.

Related content which might interest you: Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Source: International Congress 2015 – Screening strategies in TB Year: 2015 Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015 Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection Source: International Congress 2016 – Latent tuberculosis infection Year: 2016 An mRNA based IP-10 release assay for LTBI combining RT-qPCR and dried blood spots Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Significance of interferon gamma-inducible chemokines in pleural effusions Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Source: International Congress 2015 – Screening strategies in TB Year: 2015 LATE-BREAKING ABSTRACT: The performance of flow cytometry in the diagnosis of latent tuberculosis infection in patients under treatment with anti-TNFa and other biological agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015